Products manufactured

The UCSF HICTF and GMP Facility manufactures the following regulatory T cell therapy products:

• Ex vivo Expanded CD4⁺CD127^lo/-CD25⁺ Alloantigen-Reactive Regulatory T Cells (arTregs) 
• Ex vivo Expanded CD4⁺CD127^lo/-CD25⁺ Polyclonal Regulatory T Cells [PDF of paper with expansion protocol]
• Cryopreserved Ex Vivo Expanded Polyclonal CD4⁺CD127^lo/-CD25⁺ T Regulatory Cells (cePolyTregs)